株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

腸溶性ソフトゲルカプセルの世界市場: 市場機会分析および将来予測

Enteric Softgel Capsules Market by Application (Health Supplements and Pharmaceuticals), and Sales Channel (Supermarket & Hypermarket, Pharmacy & Drug Store, and Online Provider): Global Opportunity Analysis and Industry Forecast, 2018 - 2025

発行 Allied Market Research 商品コード 759012
出版日 ページ情報 英文 151 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.69円で換算しております。
Back to Top
腸溶性ソフトゲルカプセルの世界市場: 市場機会分析および将来予測 Enteric Softgel Capsules Market by Application (Health Supplements and Pharmaceuticals), and Sales Channel (Supermarket & Hypermarket, Pharmacy & Drug Store, and Online Provider): Global Opportunity Analysis and Industry Forecast, 2018 - 2025
出版日: 2018年11月18日 ページ情報: 英文 151 Pages
概要

当レポートでは、腸溶性ソフトゲルカプセルの世界市場を取り上げ、市場成長促進要因や市場機会、市場動向、また市場競争等に関する広範な調査を通じて現行市場の分析と将来予測を行っています。さらに市場を用途別、販売チャンネル別、および地域別に分類し、それぞれ詳細な分析と予測とを提供しています。

第1章 序論

  • 当レポートについて
  • 当レポートの成果
  • 主な市場分野
  • 調査手法

第2章 エグゼクティブ・サマリー

  • 重要な調査結果
    • CXOの視点

第3章 市場概要

  • 市場の定義および範囲
  • 重要な調査結果
    • 主要出資者
    • 主要企業の市場ポジショニング
  • 市場ダイナミクス
    • 市場成長促進要因
    • 市場成長阻害要因
    • 市場機会
    • 影響度分析

第4章 腸溶性ソフトゲルカプセル市場の用途別分析

  • 概要
    • 市場規模および将来予測
  • 健康補助食品
  • 医薬品

第5章 腸溶性ソフトゲルカプセル市場の販売チャンネル別分析

  • 概要
    • 市場規模および将来予測
  • スーパーマーケットおよびハイパーマーケット
  • 薬局・薬店
  • オンライン販売店

第6章 腸溶性ソフトゲルカプセル市場の地域別分析

  • 概要
    • 市場規模および将来予測
  • 北米
    • 主要市場動向、成長要因、および市場機会
    • 国別市場規模および将来予測
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • 他の欧州諸国
  • アジア太平洋
    • 日本
    • 中国
    • オーストラリア
    • インド
    • 韓国
    • 他のアジア太平洋諸国
  • LAMEA (ラテンアメリカ、中東、およびアフリカ) 地域
    • ブラジル
    • サウジアラビア
    • 南アフリカ
    • 他のLAMEA諸国

第7章 主要企業プロファイル

  • BASF SE
  • Catalent, Inc.
  • Colorcon, Inc.
  • 富士カプセル株式会社
  • Procaps
  • NOW Foods Inc.
  • Thermo Fisher Scientific, Inc. (Patheon)
  • Sirio Pharma Co., LTD
  • Super Spectrim
  • Trigen Laboratories, Inc.
図表

List of Tables

  • TABLE 01. GLOBAL ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
  • TABLE 02. HEALTH SUPPLEMENTS ENTERIC SOFTGEL CAPSULES MARKET, BY REGION, 20172025 ($MILLION)
  • TABLE 03. PHARMACEUTICALS ENTERIC SOFTGEL CAPSULES MARKET, BY REGION, 20172025 ($MILLION)
  • TABLE 04. GLOBAL ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
  • TABLE 05. SUPERMARKETS & HYPERMARKETS ENTERIC SOFTGEL CAPSULES MARKET, BY REGION, 20172025 ($MILLION)
  • TABLE 06. PHARMACY & DRUG STORE ENTERIC SOFTGEL CAPSULES MARKET, BY REGION, 20172025 ($MILLION)
  • TABLE 07. ONLINE PROVIDERS ENTERIC SOFTGEL CAPSULES MARKET, BY REGION, 20172025 ($MILLION)
  • TABLE 08. ENTERIC SOFTGEL CAPSULES MARKET, BY REGION, 20172025 ($MILLION)
  • TABLE 09. NORTH AMERICA ENTERIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 20172025 ($MILLION)
  • TABLE 10. U.S. ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
  • TABLE 11. U.S. ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
  • TABLE 12. CANADA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
  • TABLE 13. CANADA ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
  • TABLE 14. MEXICO ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
  • TABLE 15. MEXICO ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
  • TABLE 16. NORTH AMERICA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
  • TABLE 17. NORTH AMERICA ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
  • TABLE 18. EUROPE ENTERIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 20172025 ($MILLION)
  • TABLE 19. GERMANY ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
  • TABLE 20. GERMANY ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
  • TABLE 21. FRANCE ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
  • TABLE 22. FRANCE ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
  • TABLE 23. UK ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
  • TABLE 24. UK ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
  • TABLE 25. ITALY ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
  • TABLE 26. ITALY ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
  • TABLE 27. SPAIN ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
  • TABLE 28. SPAIN ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
  • TABLE 29. REST OF EUROPE ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
  • TABLE 30. REST OF EUROPE ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
  • TABLE 31. EUROPE ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
  • TABLE 32. EUROPE ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
  • TABLE 33. ASIA- PACIFIC ENTERIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 20172025 ($MILLION)
  • TABLE 34. JAPAN ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
  • TABLE 35. JAPAN ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
  • TABLE 36. CHINA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
  • TABLE 37. CHINA ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
  • TABLE 38. AUSTRALIA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
  • TABLE 39. AUSTRALIA ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
  • TABLE 40. INDIA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
  • TABLE 41. INDIA ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
  • TABLE 42. SOUTH KOREA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
  • TABLE 43. SOUTH KOREA ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
  • TABLE 44. REST OF ASIA-PACIFIC ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
  • TABLE 45. REST OF ASIA-PACIFIC ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
  • TABLE 46. ASIA-PACIFIC ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
  • TABLE 47. ASIA-PACIFIC ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
  • TABLE 48. LAMEA ENTERIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 20172025 ($MILLION)
  • TABLE 49. BRAZIL ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
  • TABLE 50. BRAZIL ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
  • TABLE 51. SAUDI ARABIA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
  • TABLE 52. SAUDI ARABIA ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
  • TABLE 53. SOUTH AFRICA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
  • TABLE 54. SOUTH AFRICA ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
  • TABLE 55. REST OF LAMEA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
  • TABLE 56. REST OF LAMEA ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
  • TABLE 57. LAMEA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
  • TABLE 58. LAMEA ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
  • TABLE 59. BASF SE: COMPANY SNAPSHOT
  • TABLE 60. BASF SE: OPERATING SEGMENTS
  • TABLE 61. BASF SE: PRODUCT PORTFOLIO
  • TABLE 62. CATALENT, INC.: COMPANY SNAPSHOT
  • TABLE 63. CATALENT, INC: OPERATING SEGMENTS
  • TABLE 64. CATALENT, INC.: PRODUCT PORTFOLIO
  • TABLE 65. COLORCON, INC.: COMPANY SNAPSHOT
  • TABLE 66. COLORCON, INC.: OPERATING SEGMENTS
  • TABLE 67. COLORCON, INC.: PRODUCT PORTFOLIO
  • TABLE 68. FUJI CAPSULES CO., LTD.: COMPANY SNAPSHOT
  • TABLE 69. FUJI CAPSULES CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 70. PROCAPS.: COMPANY SNAPSHOT
  • TABLE 71. PROCAPS.: OPERATING SEGMENTS
  • TABLE 72. PROCAPS.: PRODUCT PORTFOLIO
  • TABLE 73. NOW FOODS: COMPANY SNAPSHOT
  • TABLE 74. NOW FOODS: OPERATING SEGMENTS
  • TABLE 75. NOW FOODS: PRODUCT PORTFOLIO
  • TABLE 76. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
  • TABLE 77. THERMO FISHER SCIENTIFIC: OPERATING SEGMENTS
  • TABLE 78. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
  • TABLE 79. SIRIO PHARMA CO., LTD.: COMPANY SNAPSHOT
  • TABLE 80. SIRIO PHARMA CO., LTD.: OPERATING SEGMENTS
  • TABLE 81. SIRIO PHARMA CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 82. SUPER SPECTRIM.: COMPANY SNAPSHOT
  • TABLE 83. SUPER SPECTRIM: OPERATING SEGMENTS
  • TABLE 84. SUPER SPECTRIM: PRODUCT PORTFOLIO
  • TABLE 85. TRIGEN LABORATORIES, INC..: COMPANY SNAPSHOT
  • TABLE 86. TRIGEN LABORATORIES, INC.: OPERATING SEGMENTS
  • TABLE 87. TRIGEN LABORATORIES, INC.: PRODUCT PORTFOLIO

List of Figures

  • FIGURE 01. ENTERIC SOFTGEL CAPSULES MARKET SEGMENTATION
  • FIGURE 02. TOP INVESTMENT POCKETS IN THE GLOBAL ENTERIC SOFTGEL CAPSULES MARKET
  • FIGURE 03. TOP PLAYER POSITIONING, 2017
  • FIGURE 04. IMPACT ANALYSES
  • FIGURE 05. COMPARATIVE ANALYSIS OF HEALTH SUPPLEMENTS ENTERIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 2017 & 2025 ($MILLION)
  • FIGURE 06. COMPARATIVE ANALYSIS OF PHARMACEUTICALS ENTERIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 2017 & 2025 ($MILLION)
  • FIGURE 07. COMPARATIVE ANALYSIS OF SUPERMARKET & HYPERMARKET ENTERIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 2017 & 2025 ($MILLION)
  • FIGURE 08. COMPARATIVE ANALYSIS OF PHARMACY & DRUG STORE ENTERIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 2017 & 2025 ($MILLION)
  • FIGURE 09. COMPARATIVE ANALYSIS OF ONLINE PROVIDER ENTERIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 2017 & 2025 ($MILLION)
  • FIGURE 10. BASF SE: REVENUE, 20152017 ($MILLION)
  • FIGURE 11. BASF SE: REVENUE SHARE BY BUSINESS SEGMENT, 2017 (%)
  • FIGURE 12. BASF SE: REVENUE SHARE BY GEOGRAPHIC SEGMENT, 2017 (%)
  • FIGURE 13. CATALENT, INC.: REVENUE, 20152017 ($MILLION)
  • FIGURE 14. CATALENT, INC.: REVENUE SHARE BY BUSINESS SEGMENT, 2017 (%)
  • FIGURE 15. CATALENT, INC: REVENUE SHARE BY GEOGRAPHIC SEGMENT, 2017 (%)
  • FIGURE 16. THERMO FISHER SCIENTIFIC: REVENUE, 20152017 ($MILLION)
  • FIGURE 17. THERMO FISHER SCIENTIFIC: REVENUE SHARE BY SEGMENTS, 2017 (%)
  • FIGURE 18. THERMO FISHER SCIENTIFIC: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
目次
Product Code: LI_182938

Enteric Softgel Capsules Market Overview:

The global enteric softgel capsules market generated $1,851 million in 2017, and is projected to reach $2,589 million by 2025, registering a CAGR of 4.2% from 2018 to 2025. Soft capsules are a single-unit solid dosage form, consisting of a liquid or semi-solid drug or extract within a soft shell. Enteric softgel capsules are a form of delayed release dosage forms, which protect either the drugs from the acidity of the stomach, or the stomach from the detrimental effects of the drug.

The global enteric softgel capsules market is expected to grow at a significant rate during the forecast period, owing to growth in number of R&D activities to increase bioavailability of the drug, surge in demand for softgel health supplements, rise in consumer awareness related to preventative healthcare, and proliferation of distribution channels. Further, improvement in lifestyle pattern, rise in geriatric population, and increase in number of self-directed consumers have fueled the market growth. However, stability concern with some water-soluble compounds and high cost associated with softgel can impede the market growth.

The global enteric softgel capsules market is segmented based on application, sales channel, and region. Based on application, the market is classified as health supplements and pharmaceuticals. According to the sales channel, the market is segmented into supermarket & hypermarket, pharmacy & drug store, and online provider. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Key Benefits for Enteric Softgel Capsules Market:

  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2018 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
  • A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

Enteric Softgel Capsules Key Market Segments:

By Application

  • Health Supplements
  • Pharmaceuticals

By Sales Channel

  • Supermarket & Hypermarket
  • Pharmacy & Drug Store
  • Online Provider

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

List Of Key Players Profiled in the Report:

  • BASF SE,
  • Catalent, Inc.
  • Colorcon Inc.
  • Fuji Capsules Co. Ltd.
  • InovoBiologic Inc.
  • NOW Foods Inc.
  • Sirio Pharma Co., Ltd.
  • Super Spectrim
  • Thermo Fisher Scientific, Inc. (Patheon)
  • Trigen Laboratories, Inc.

List Of Other Players in the Value Chain (These players are not profiled in the report. The same will be included on request.)

  • Nature's Way Products, LLC.
  • Lonza Group Ltd
  • PROCAPS (softigel)

Table of Contents

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key benefits for stakeholders
  • 1.3. Key market segments
    • 1.3.1. List of key players profiled in the report
  • 1.4. Research methodology
    • 1.4.1. Secondary research
    • 1.4.2. Primary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. Key findings of the study
    • 2.1.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top investment pockets
    • 3.2.2. Top player positioning
  • 3.3. MARKET DYNAMICS
    • 3.3.1. Drivers
      • 3.3.1.1. Surge in adoption of softgel capsules
      • 3.3.1.2. Rapid growth of e-commerce
      • 3.3.1.3. Surge in healthcare expenditure worldwide
    • 3.3.2. Restraints
      • 3.3.2.1. Poor demand in under developed countries
    • 3.3.3. Opportunities
      • 3.3.3.1. Growth opportunities in emerging markets
    • 3.3.4. Impact analyses

CHAPTER 4: ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Health supplements
    • 4.2.1. Key market trends, growth factors, and opportunities
    • 4.2.2. Market size and forecast
    • 4.2.3. Market analysis, by country
  • 4.3. Pharmaceuticals
    • 4.3.1. Key market trends, growth factors, and opportunities
    • 4.3.2. Market size and forecast
    • 4.3.3. Market analysis, by country

CHAPTER 5: ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Supermarket & hypermarket
    • 5.2.1. Market size and forecast
    • 5.2.2. Market analysis, by country
  • 5.3. Pharmacy & drug store
    • 5.3.1. Market size and forecast
    • 5.3.2. Market analysis, by country
  • 5.4. Online Provider
    • 5.4.1. Market size and forecast
    • 5.4.2. Market analysis, by country

CHAPTER 6: ENTERIC SOFTGEL CAPSULES MARKET BY REGION

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. North America
    • 6.2.1. Key market trends, growth factors, and opportunities
    • 6.2.2. Market size and forecast, by country
      • 6.2.2.1. U.S.
      • 6.2.2.1.1. U.S. enteric softgel capsules market, by application
      • 6.2.2.1.2. U.S. enteric softgel capsules market, by sales channel
      • 6.2.2.2. Canada
      • 6.2.2.2.1. Canada enteric softgel capsules market, by application
      • 6.2.2.2.2. Canada enteric softgel capsules market, by sales channel
      • 6.2.2.3. Mexico
      • 6.2.2.3.1. Mexico enteric softgel capsules market, by application
      • 6.2.2.3.2. Mexico enteric softgel capsules market, by sales channel
    • 6.2.3. North America enteric softgel capsules market, by application
    • 6.2.4. North America enteric softgel capsules market, by sales channel
  • 6.3. Europe
    • 6.3.1. Key market trends, growth factors, and opportunities
    • 6.3.2. Market size and forecast, by country
      • 6.3.2.1. Germany
      • 6.3.2.1.1. Germany enteric softgel capsules market, by application
      • 6.3.2.1.2. Germany enteric softgel capsules market, by sales channel
      • 6.3.2.2. France
      • 6.3.2.2.1. France enteric softgel capsules market, by application
      • 6.3.2.2.2. France enteric softgel capsules market, by sales channel
      • 6.3.2.3. UK
      • 6.3.2.3.1. UK enteric softgel capsules market, by application
      • 6.3.2.3.2. UK enteric softgel capsules market, by sales channel
      • 6.3.2.4. Italy
      • 6.3.2.4.1. Italy enteric softgel capsules market, by application
      • 6.3.2.4.2. Italy enteric softgel capsules market, by sales channel
      • 6.3.2.5. Spain
      • 6.3.2.5.1. Spain enteric softgel capsules market, by application
      • 6.3.2.5.2. Spain enteric softgel capsules market, by sales channel
      • 6.3.2.6. Rest of Europe
      • 6.3.2.6.1. Rest of Europe enteric softgel capsules market, by application
      • 6.3.2.6.2. Rest of Europe enteric softgel capsules market, by sales channel
    • 6.3.3. Europe enteric softgel capsules market, by application
    • 6.3.4. Europe enteric softgel capsules market, by sales channel
  • 6.4. Asia-Pacific
    • 6.4.1. Key market trends, growth factors, and opportunities
    • 6.4.2. Market size and forecast, by country
      • 6.4.2.1. Japan
      • 6.4.2.1.1. Japan enteric softgel capsules market, by application
      • 6.4.2.1.2. Japan enteric softgel capsules market, by sales channel
      • 6.4.2.2. China
      • 6.4.2.2.1. China enteric softgel capsules market, by application
      • 6.4.2.2.2. China enteric softgel capsules market, by sales channel
      • 6.4.2.3. Australia
      • 6.4.2.3.1. Australia enteric softgel capsules market, by application
      • 6.4.2.3.2. Australia enteric softgel capsules market, by sales channel
      • 6.4.2.4. India
      • 6.4.2.4.1. India enteric softgel capsules market, by application
      • 6.4.2.4.2. India enteric softgel capsules market, by sales channel
      • 6.4.2.5. South Korea
      • 6.4.2.5.1. South Korea enteric softgel capsules market, by application
      • 6.4.2.5.2. South Korea enteric softgel capsules market, by sales channel
      • 6.4.2.6. Rest of Asia-Pacific
      • 6.4.2.6.1. Rest of Asia-Pacific enteric softgel capsules market, by application
      • 6.4.2.6.2. Rest of Asia-Pacific enteric softgel capsules market, by sales channel
    • 6.4.3. Asia-Pacific enteric softgel capsules market, by application
    • 6.4.4. Asia-Pacific enteric softgel capsules market, by sales channel
  • 6.5. LAMEA
    • 6.5.1. Key market trends, growth factors, and opportunities
    • 6.5.2. Market size and forecast, by country
      • 6.5.2.1. Brazil
      • 6.5.2.1.1. Brazil enteric softgel capsules market, by application
      • 6.5.2.1.2. Brazil enteric softgel capsules market, by sales channel
      • 6.5.2.2. Saudi Arabia
      • 6.5.2.2.1. Saudi Arabia enteric softgel capsules market, by application
      • 6.5.2.2.2. Saudi Arabia enteric softgel capsules market, by sales channel
      • 6.5.2.3. South Africa
      • 6.5.2.3.1. South Africa enteric softgel capsules market, by application
      • 6.5.2.3.2. South Africa enteric softgel capsules market, by sales channel
      • 6.5.2.4. Rest of LAMEA
      • 6.5.2.4.1. Rest of LAMEA enteric softgel capsules market, by application
      • 6.5.2.4.2. Rest of LAMEA enteric softgel capsules market, by sales channel
    • 6.5.3. LAMEA enteric softgel capsules market, by application
    • 6.5.4. LAMEA enteric softgel capsules market, by sales channel
  • 6.6. BASF SE
    • 6.6.1. Company overview
    • 6.6.2. Company snapshot
    • 6.6.3. Operating business segments
    • 6.6.4. Product Portfolio
    • 6.6.5. Business performance
  • 6.7. Catalent, Inc.
    • 6.7.1. Company overview
    • 6.7.2. Company snapshot
    • 6.7.3. Operating business segments
    • 6.7.4. Product Portfolio
    • 6.7.5. Business performance
  • 6.8. Colorcon, Inc.
    • 6.8.1. Company overview
    • 6.8.2. Company snapshot
    • 6.8.3. Operating business segments
    • 6.8.4. Product Portfolio
  • 6.9. Fuji Capsules Co., Ltd.
    • 6.9.1. Company overview
    • 6.9.2. Company snapshot
    • 6.9.3. Product Portfolio
  • 6.10. Procaps
    • 6.10.1. Company overview
    • 6.10.2. Company snapshot
    • 6.10.3. Operating business segments
    • 6.10.4. Product Portfolio
  • 6.11. NOW Foods Inc.
    • 6.11.1. Company overview
    • 6.11.2. Company snapshot
    • 6.11.3. Operating business segments
    • 6.11.4. Product Portfolio
  • 6.12. Thermo Fisher Scientific, Inc. (Patheon)
    • 6.12.1. Company overview
    • 6.12.2. Company snapshot
    • 6.12.3. Operating business segments
    • 6.12.4. Product Portfolio
    • 6.12.5. Business performance
    • 6.12.6. Key strategic moves and developments
  • 6.13. Sirio Pharma Co., LTD
    • 6.13.1. Company overview
    • 6.13.2. Company snapshot
    • 6.13.3. Operating business segments
    • 6.13.4. Product Portfolio
  • 6.14. Super Spectrim
    • 6.14.1. Company overview
    • 6.14.2. Company snapshot
    • 6.14.3. Operating business segments
    • 6.14.4. Product Portfolio
  • 6.15. Trigen Laboratories, Inc.
    • 6.15.1. Company overview
    • 6.15.2. Company snapshot
    • 6.15.3. Operating business segments
    • 6.15.4. Product Portfolio
Back to Top